Lipids

, Volume 9, Issue 6, pp 374–381 | Cite as

DDT absorption and chylomicron transport in rat

  • Dorothy M. E. Pocock
  • Alan Vost
Article

Abstract

Male rats were fed 100 nM dichlorodiphenyltrichloroethane-14C in oil by gastric tube. Recovery of dichlorodiphenyltrichloroethane-14C in thoracic duct lymph was 60% in 12 hr. Lymph dichlorodiphenyltrichloroethane-14C (97%) occurred in lipoproteins of d<1.006, designated chylomicrons. Mechanical separation of chylomicron triglyceride core (labeled with triglyceride-3H) from chylomicron membrane (labeled with phospholipid-32P) showed that 97% dichlorodiphenyltrichloroethane-14C was present in triglyceride core. To investigate possible association of plasma clearance of the two core lipids, rats were pulse injected with chylomicrons, doubly labeled with triglyceride-3H and dichlorodiphenyltrichloroethane-14C. The decay of dichlorodiphenyltrichloroethane-14C in sequential serum samples was rapid (T1/2=2 min) and was independent of triglyceride-3H decay. In tissues removed 14 min after injection of chylomicrons, 30% administered dichlorodiphenyltrichloroethane-14C was found in liver but only 1% in adipose tissue. In hepatectomized (eviscerated) rats, the decay of serum dichlorodiphenyltrichloroethane-14C (T1/2=10 min) was also independent of and more rapid than triglyceride-3H decay. With sucrose density gradients, it was shown that chylomicron dichlorodiphenyltrichloroethane-14C transferred to higher density serum proteins in vitro and in vivo and to bovine albumin in vitro. Thus, dichlorodiphenyltrichloroethane was transported from intestine largely in the triglyderide phase of chylomicrons; disappearance of chylomicron-dichlorodiphenyltrichloroethane from the systemic circulation was rapid and partly independent of the presence of the liver and of triglyceride hydrolysis; some dichlorodiphenyltrichloroethane was transported from serum chylomicrons to albumin or other plasma proteins before tissue uptake.

Keywords

Sucrose Density Gradient Intestinal Lymph Hydrophobic Lipid Chylomicron Triglyceride Lymph Chylomicron 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Finnegan, J.K., H.B. Haag, and P.S. Larson, Proc. Soc. Exptl. Biol. Med. 72:357 (1949).Google Scholar
  2. 2.
    Hayes, W.J. Jr., Annu. Rev. Pharmacol. 5:27 (1965).CrossRefGoogle Scholar
  3. 3.
    Judah, J.D., Brit. J. Pharmacol. 4:120 (1949).PubMedGoogle Scholar
  4. 4.
    Rothe, C.F., A.M. Mattson, R.M. Nueslein, and W.J. Hayes, Amer. Med. Assoc. Arch. Ind. Health, 16:82 (1957).Google Scholar
  5. 5.
    Bollman, J.L., J.C. Cain, and J.H. Grindlay, J. Lab. Clin. Med. 33:1349 (1948).Google Scholar
  6. 6.
    Windmueller, H.G., F.T. Lindgren, W.J. Lossow, and R.I. Levy, Biochim. Biophys. Acta 202:507 (1970).PubMedGoogle Scholar
  7. 7.
    Havel, R.J., H.A. Eder, and J.H. Bragdon, J. Clin. Invest. 34:1345 (1955).PubMedGoogle Scholar
  8. 8.
    Zilversmit, D.B., J. Lipid Res. 9:180 (1968).PubMedGoogle Scholar
  9. 9.
    Shepherd, P., and W.J. Simmonds, Aust. J. Exptl. Biol. Med. Sci. 37:1 (1959).Google Scholar
  10. 10.
    Pinter, G.G., and D.B. Zilversmit, Biochim. Biophys. Acta 59:116 (1962).PubMedCrossRefGoogle Scholar
  11. 11.
    Folch, J., M. Lees, and G.J. Sloane Stanley, J. Biol. Chem. 226:497 (1957).PubMedGoogle Scholar
  12. 12.
    Dole, V.P., J. Clin. Invest. 35:150 (1956).PubMedGoogle Scholar
  13. 13.
    Rose, H.G., and M. Oklander, J. Lipid Res. 6:428 (1965).PubMedGoogle Scholar
  14. 14.
    Pocock, D.M.-E., S. Rafal, and A. Vost, J. Chromato. Sci. 10:72 (1972).Google Scholar
  15. 15.
    Vost, A. J. Lipid Res. 13:695 (1972).PubMedGoogle Scholar
  16. 16.
    Morgan, R.G.H., Quart. J. Exp. Physiol. 49:457 (1964).PubMedGoogle Scholar
  17. 17.
    Chaikoff, I.L., B. Bloom, B.P. Stevens, W.O. Reinhardt, and W.G. Dauben, J. Biol. Chem. 190:431 (1951).PubMedGoogle Scholar
  18. 18.
    Bloom, B., I.L. Chaikoff, and W.O. Reinhardt, Amer. J. Physiol. 166:451 (1951).PubMedGoogle Scholar
  19. 19.
    Quintăo, E., S.M. Grundy, and E.H. Ahrens Jr., J. Lipid Res. 12:221 (1971).PubMedGoogle Scholar
  20. 20.
    Savary, P., and M.J. Constantin, Biochim. Biophys. Acta 137:264 (1967)PubMedGoogle Scholar
  21. 21.
    Peake, I.R., H.G. Windmueller, and J.G. Bieri,Ibid. 260:679 (1972).PubMedGoogle Scholar
  22. 22.
    Haque, R., I.J. Tinsley, and D. Schmedding, Mol. Pharmacol. 9:17 (1972).Google Scholar
  23. 23.
    Diamond, J.M., and E.M. Wright, Ann. Rev. Physiol. 31:581 (1969).CrossRefGoogle Scholar
  24. 24.
    Hogben, C.A.M., L.S. Schanker, D.J. Tocco, and B.B. Brodie, J. Pharmacol. Exp. Therap. 120:540 (1957).Google Scholar
  25. 25.
    Zilversmit, D.B., in “Structural and Functional Aspects of Lipoproteins in Living Systems,” Academic Press, New York, N.Y. 1969, p. 329.Google Scholar
  26. 26.
    Lossow, W.J., F.T. Lindgren, and L.C. Jensen, Biochim. Biophys. Acta 144:670 (1967).PubMedGoogle Scholar
  27. 27.
    Redgrave, T.G., J. Clin. Invest. 49:465 (1970).PubMedCrossRefGoogle Scholar

Copyright information

© American Oil Chemists’ Society 1974

Authors and Affiliations

  • Dorothy M. E. Pocock
    • 1
  • Alan Vost
    • 1
  1. 1.McGill University Medical ClinicMontreal General HospitalMontrealCanada

Personalised recommendations